文献速递鼻科

慢性鼻窦炎伴鼻息肉修正手术率:危险因素Meta分析

Revision surgery rates in chronic rhinosinusitis with nasal polyps: meta-analysis of risk factors.
PubMed 文献 · Int Forum Allergy Rhinol · 2019-11-21

变应性真菌性鼻窦炎、阿司匹林加重呼吸道疾病、哮喘、既往鼻息肉切除术及2008年前发表与修正率升高相关(均P<0.05)。

要点

  • 慢性鼻窦炎伴鼻息肉内镜鼻窦术后长期修正率约14%-24%。
  • 变应性真菌性鼻窦炎、阿司匹林加重呼吸道疾病、哮喘及既往息肉切除者修正风险更高。
  • 识别危险因素有助于管理患者预期并制定个体化治疗。

核心结论

  • 慢性鼻窦炎伴鼻息肉患者内镜鼻窦术后息肉可复发,长期修正手术率约为14%至24%。
  • 识别修正手术危险因素有助于管理患者预期并确定最佳个体化治疗。

研究设计与样本

  • 系统综述与Meta分析,遵循PRISMA指南,检索PubMed、Scopus和Cochrane系统综述数据库。

主要发现

  • 汇总修正手术率为18.6%(95%CI 14.1%-23.6%)。
  • 可提取随访数据的研究中,加权平均随访89.6个月,平均修正率为16.2%。
  • 变应性真菌性鼻窦炎修正率为28.7%,阿司匹林加重呼吸道疾病为27.2%,哮喘为22.6%,既往鼻息肉切除术为26.0%,2008年前发表为22.7%(均P<0.05)。

关键数值与推荐

  • 合并变应性真菌性鼻窦炎者修正率为28.7%。
  • 合并阿司匹林加重呼吸道疾病者修正率为27.2%。
  • 合并哮喘者修正率为22.6%。
  • 有既往鼻息肉切除术史者修正率为26.0%。
  • 2008年前发表的研究修正率为22.7%。

临床怎么用

  • 可用14%-24%的长期修正率区间向慢性鼻窦炎伴鼻息肉患者说明术后复发风险。
  • 对合并变应性真菌性鼻窦炎、阿司匹林加重呼吸道疾病、哮喘或有既往息肉切除史者应加强随访与个体化治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Wide variations in revision endoscopic sinus surgery (ESS) rates for chronic rhinosinusitis with nasal polyposis (CRSwNP) have been reported. It is important to understand expected revision rates and factors that impact the need for revision. METHODS: A literature search was conducted on PubMed, Scopus, and the Cochrane Database of Systematic Reviews. Following PRISMA guidelines, a systematic review and meta-analysis was performed on studies that reported revision surgery data for CRSwNP patients. RESULTS: Forty-five studies with 34,220 subjects were meta-analyzed, with an overall revision rate of 18.6% (95% confidence interval, 14.1%-23.6%). Studies with extractable follow-up data reported a mean revision rate of 16.2% over a weighted mean follow-up of 89.6 months. Factors associated with increased revision rates included allergic fungal rhinosinusitis (28.7%), aspirin-exacerbated respiratory disease (27.2%), asthma (22.6%), prior polypectomy (26.0%), and publication prior to 2008 (22.7%) (p < 0.05 for all). CONCLUSION: Although polyps can recur after ESS, reported long-term ESS revision rates are approximately 14% to 24%. Identifying risk factors for revision surgery can help manage patient expectations and determine optimal personalized treatments.

来源:Int Forum Allergy Rhinol,查看原文。版权归原作者所有。

引用

  1. Loftus CA, Soler ZM, Koochakzadeh S, et al. Revision surgery rates in chronic rhinosinusitis with nasal polyps: meta-analysis of risk factors. Int Forum Allergy Rhinol. 2019. PMID: 31752051. doi:10.1002/alr.22487

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。